M

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Director GMP Quality Assurance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA

About the Job

Requirements

  • A bachelor's degree in a scientific discipline such as chemistry or pharmaceutical sciences, or a related field, and 10 or more years of progressive experience in biotech or pharmaceutical GMP quality assurance, including direct experience in small molecule drug development.
  • Demonstrated experience supporting a small molecule drug product through late-stage development and commercial readiness, including process validation, process performance qualification, and technology transfer to commercial manufacturing.
  • Demonstrated experience supporting GMP Quality across drug substance, drug product, formulation, packaging, labeling, and distribution, including testing, stability, and retention.
  • Deep knowledge of global GMP regulations and guidance, including 21 CFR Parts 210 and 211, EU GMP/EudraLex Volume 4, relevant ICH guidelines, and other applicable standards.
  • Familiarity with 21 CFR Part 11 and EU Annex 11 computer systems validation requirements.
  • Experience with disposition and release of investigational materials in compliance with applicable GMP requirements.
  • Track record of supporting FDA regulatory inspections.
  • Demonstrated experience with GMP audits, investigations, root cause analysis, and CAPA development and implementation.
  • Experience managing and developing direct reports, with a focus on mentorship and professional growth.
  • Willingness to travel domestically and internationally for inspections, vendor oversight, and industry events.

Responsibilities

  • Provide GMP Quality oversight for development programs from early development through commercial launch, ensuring phase-appropriate systems and inspection readiness.
  • Represent GMP Quality on internal cross-functional teams and program initiatives, advising on development and manufacturing decisions.
  • Provide GMP Quality oversight of manufacturing and testing at external CDMOs/CMOs in partnership with Technical Operations.
  • Ensure timely batch record review, product disposition, and release of investigational materials.
  • Lead GMP QA investigations and ensure timely and effective resolution of deviations, complaints, audit and inspection findings, and associated CAPAs across internal and outsourced GMP activities.
  • Develop and continuously improve phase-appropriate GMP Quality Systems, processes, and SOPs aligned with ICH Q9 and ICH Q10 principles.
  • Support commercial readiness, including process performance qualification, technology transfer, and preparation for commercial manufacturing and launch.
  • Manage and develop direct reports while mentoring and supporting professional growth across the Quality team.
  • Build communication channels across the organization for sharing information and influence senior management decisions through persuasive arguments.
  • Address differing opinions respectfully to build support for decisions.
  • Champion partnerships and connections across the organization, address issues that could undermine team relationships, and recognize team and individual contributions.
  • Address gaps and leverage strengths to achieve results, maintain clarity on priorities during change, and remove barriers that put functional or corporate goals at risk.
  • Remove barriers to staff development, empower staff to make their own decisions, stay current on industry trends, and keep direct reports prepared and responsive.

Desired Qualifications

  • Technical experience in drug substance or drug product manufacturing and/or testing is preferred.
  • Experience with EU/EEA competent authorities and other global regulatory authorities is desirable.

About the Company

Maze Therapeutics

Clinical-stage biotech developing precision kidney therapies

Maze Therapeutics is a clinical-stage biotechnology company that builds precision medicines for diseases with large unmet needs by using human genetics to copy protective genetic variants into small-molecule drugs. Its Compass platform maps genetic insights to therapeutic targets through variant functionalization, guiding drug discovery across research, preclinical, and clinical stages. Its lead program MZE829 targets APOL1-driven kidney disease, while MZE782 is in development for chronic kidney disease and phenylketonuria. Unlike many peers, Maze focuses on turning natural genetic protections into medicines and aims to develop and commercialize its own therapies.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Maze Therapeutics

See more jobs